Benefit from Reslizumab Treatment in a Patient with Chronic Spontaneous Urticaria and Cold Urticaria

Abstract

Chronic urticaria (CU) is a group of common and debilitating conditions containing both chronic spontaneous urticaria (CSU) and chronic inducible urticarias (CIndU) including cold urticaria (ColdU) [1]. While antihistamines and omalizumab are effective treatments for both CSU and ColdU [2], many patients show insufficient response to either or both of these treatments [3], and additional and better therapies are needed [4].

This article is protected by copyright. All rights reserved.

http://ift.tt/2yaQdNg